US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | United Therapeutics Corporation | $536.59 | -2.7% | $22.78B | 19.3 | 7.9% | — | Healthcare | 83.9% | 5.9% | ||
| 2 | Jazz Pharmaceuticals plc | $224.66 | -1% | $14.09B | -38.5 | -98.5% | — | Healthcare | 107.6% | 9.2% | ||
| 3 | Alkermes plc | $44.99 | 1.1% | $7.5B | 31.5 | -56.9% | — | Healthcare | 53.4% | 3.2% | ||
| 4 | Liquidia Corporation | $71.07 | 3.5% | $6.32B | -88.8 | 108.9% | — | Healthcare | 421% | 1936.7% | ||
| 5 | Arcutis Biotherapeutics, Inc. | $26.21 | -0% | $3.28B | -201.6 | 96.7% | — | Healthcare | 91.7% | 95.3% | ||
| 6 | Zai Lab Limited | $18.18 | 1.7% | $2.01B | -11.4 | 87.9% | — | Healthcare | -50.8% | 8.4% | ||
| 7 | ADMA Biologics, Inc. | $8.31 | -1.3% | $1.93B | 13.9 | -20% | — | Healthcare | -54.2% | 11% | ||
| 8 | Unicycive Therapeutics, Inc. | $6.85 | -2.8% | $1.64B | -4.1 | 45.1% | — | Healthcare | 2.5% | — | ||
| 9 | Mineralys Therapeutics, Inc. | $24.63 | -2% | $1.63B | -10.8 | 45% | — | Healthcare | 79.4% | — | ||
| 10 | Ardelyx, Inc. | $6.05 | 3.6% | $1.48B | -23.3 | -4.8% | — | Healthcare | 67.6% | 18.2% | ||
| 11 | Phathom Pharmaceuticals, Inc. | $10.88 | -1.1% | $864M | -3.6 | 59.5% | — | Healthcare | -0.2% | 150.3% | ||
| 12 | Theravance Biopharma, Inc. | $16.58 | -0.8% | $855M | 8.0 | 286.8% | — | Healthcare | 56.1% | 68.2% | ||
| 13 | Tenax Therapeutics, Inc. | $12.00 | 1.1% | $543M | -9.0 | 43.1% | — | Healthcare | 111.6% | — | ||
| 14 | Amarin Corporation plc | $16.03 | 1.6% | $333M | -8.9 | 62.1% | — | Healthcare | 20.3% | 0.3% | ||
| 15 | Akebia Therapeutics, Inc. | $1.07 | 4.9% | $287M | -51.4 | 63.3% | — | Healthcare | -69.9% | 25.7% | ||
| 16 | Sol-Gel Technologies Ltd. | $74.46 | 5.8% | $209M | -33.8 | 70.2% | — | Healthcare | 942.9% | 282.9% | ||
| 17 | Jyong Biotech Ltd. Ordinary Shares | $1.56 | -2.5% | $116M | -39.3 | — | — | Healthcare | -80.5% | — | ||
| 18 | Milestone Pharmaceuticals Inc. | $1.30 | -0.8% | $112M | -1.7 | 13.9% | — | Healthcare | -24.4% | — | ||
| 19 | Pelthos Therapeutics Inc. | $28.56 | 5.7% | $95M | -1.2 | -228.1% | — | Healthcare | 142% | — | ||
| 20 | Verrica Pharmaceuticals Inc. | $5.63 | -5.2% | $60M | -3.4 | 87% | — | Healthcare | -2.8% | 417.6% | ||
| 21 | Daré Bioscience, Inc. | $2.17 | 4.3% | $32M | -1.8 | -477.4% | — | Healthcare | -25.7% | 4366.5% | ||
| 22 | Palatin Technologies, Inc. | $11.72 | -4.3% | $13M | -0.4 | -63.8% | — | Healthcare | 74.1% | 3581.2% | ||
| 23 | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | $4.37 | -16.9% | $12M | -3.1 | — | — | Healthcare | -90.1% | — | ||
| 24 | Citius Pharmaceuticals, Inc. | $0.55 | 1.2% | $6M | -0.2 | 56% | — | Healthcare | -40.1% | 3498.8% | ||
| 25 | Processa Pharmaceuticals, Inc. | $2.12 | -1.4% | $5M | -0.2 | 86.1% | — | Healthcare | 776% | — | ||
| 26 | NKGen Biotech, Inc. Common Stock | $0.06 | 0% | $3M | -0.0 | 69.6% | — | Healthcare | -75% | — | ||
| 27 | InMed Pharmaceuticals Inc. | $1.49 | 0% | $3M | -0.2 | -8939.1% | — | Healthcare | -40.6% | 13390.6% | ||
| 28 | CASI Pharmaceuticals, Inc. | $0.15 | 3.8% | $2M | -0.1 | -41.7% | 31.1% | Healthcare | -88.9% | 21.7% | ||
| 29 | OSR Holdings, Inc. | $0.39 | 2% | $2M | -0.1 | 9.5% | — | Healthcare | -75.8% | 355% | ||
| 30 | Avenue Therapeutics, Inc. | $0.27 | 0% | $889641 | -0.3 | 88% | — | Healthcare | 4% | — | ||
| 31 | Lipella Pharmaceuticals Inc. | $0.08 | 45.2% | $363930 | -0.0 | 41.3% | — | Healthcare | -96.6% | -61.4% | ||
| 32 | Jaguar Health, Inc. | $2.25 | -5.5% | $149940 | -0.0 | 87.6% | — | Healthcare | -97.7% | 156% | ||
| 33 | Windtree Therapeutics, Inc. | $0.02 | 18.9% | $453 | -0.0 | 99.1% | 100% | Healthcare | -96.9% | — |
Showing 33 stocks